UNICEF/UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases: Joint Coordinating Board (JCB) – Report on attendance at JCB in 2022 and nomination of a Member in place of Myanmar whose term expires on 31 December 2022
Loading...
Date
Journal Title
Journal ISSN
Volume Title
Publisher
World Health Organization. Regional Office for South-East Asia
Abstract
Description
The Joint Coordinating Board (JCB) of the WHO Special Programme for Research and Training in Tropical Disease Research (TDR) acts as the Governing Body of the Special Programme and is responsible for its overall policy and strategy. This paper describes the background and composition of the JCB of TDR.Currently, Myanmar represents the WHO South-East Asia Region until 31 December 2022as a Member under the terms of Paragraph 2.2.2 of the Memorandum of Understanding. The Seventy-fifth Session of the WHO Regional Committee for South-East Asia in 2022 will be called upon to decide on a Member from the Region that will replace Myanmar for a four-year term commencing 1 January 2023. Among Member States of the WHO SEA Region, Sri Lanka expressed interest to apply for membership under Paragraph 2.2.3.Currently, Sri Lanka represents the SE Asia Region as Member of JCB under Paragraph 2.2.3 and it has re-applied for membership in the same category. However, the elections could not be organized in 2022, and Sri Lanka’s term of membership was extended by one year till 31 December 2023.The Forty-fifth Session of the Joint Coordinating Board for TDR (JCB TDR) was held virtually on 15–16 June 2022. The report on attendance of Member States from the Region at the JCB session in 2022 is attached as Annex 3During the HLP Meeting, the distinguished delegate from Thailand proposed Bangladesh as Member to replace Myanmar as a Member in the JCB to represent the WHO South-East Asia Region under Paragraph 2.2.2. Sri Lanka seconded the proposal to designate Bangladesh as a Member of JCB to represent the WHO South-East Asia Region under Paragraph 2.2.2. The proposal was approved unanimously. The HLP Meeting made the following recommendation to the Organization:Action by WHO(1) Recommend to the Seventy-fifth Session of the Regional Committee that Bangladesh be nominated as a Member of the JCB of TDR to represent the WHO South-East Asia Region under Paragraph 2.2.2.The Seventy-fifth Session of the WHO South-East Asia Region is expected to take decision on the JCB Membership of Bangladesh for the period 2023 to 2026 under Paragraph 2.2.2 to replace Myanmar.This Working Paper and the HLP Meeting recommendation are submitted to the Seventy-fifth Session of the WHO Regional Committee for South-East Asia for its consideration and decision.